Carsten Thiel Insider Trading
Get free email notifications about insider trading for Carsten Thiel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Carsten Thiel. Carsten Thiel is an Chief Executive Officer in ABEONA THERAPEUTICS INC. ($AKC) and a EVP, Chief Commercial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and a SVP, EMEA & Asia Pacific in ALEXION PHARMACEUTICALS INC ($ALXN) and a Director in Karyopharm Therapeutics Inc. ($KPTI).
Address: C/O ALEXION PHARMACEUTICALS, INC. 352 KNOTTER DRIVE CHESHIRE 06410 CT
Companies in which Carsten Thiel is an Insider
ABEONA THERAPEUTICS INC.
Trading Symbol: AKCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Carsten Thiel: Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Apr 02 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Carsten Thiel: EVP, Chief Commercial Officer, SVP, EMEA & Asia Pacific
Holdings: 33,860 shares
Current Value: $4,324,599
Latest Transaction: Mar 06 2017
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Karyopharm Therapeutics Inc.
Trading Symbol: KPTIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Carsten Thiel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 04 2018
$KPTI Market Capitalization: $416.55M
$KPTI Previous Close: $10.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Carsten Thiel
Sentiment: All, AKC, ALXN, KPTI
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 04 2018 | KPTI | Karyopharm Therape ... | Thiel Carsten | Director | Option Exercise | A | 21.05 | 34,000 | 715,700 | 34,000 | |
Apr 02 2018 | AKC | ABEONA THERAPEUTIC ... | Thiel Carsten | Chief Executive Off ... | Option Exercise | A | 13.65 | 262,500 | 3,583,125 | 262,500 | |
Apr 02 2018 | AKC | ABEONA THERAPEUTIC ... | Thiel Carsten | Chief Executive Off ... | Option Exercise | A | 13.65 | 87,500 | 1,194,375 | 87,500 | |
Mar 06 2017 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | EVP, Chief Commerci ... | Sell | S | 131.01 | 3,783 | 495,611 | 33,860 | 37.6 K to 33.9 K (-10.05 %) |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | EVP, Chief Commerci ... | Option Exercise | A | 131.25 | 14,800 | 1,942,500 | 29,600 | |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | EVP, Chief Commerci ... | Grant | A | 0.00 | 7,500 | 0 | 37,643 | 30.1 K to 37.6 K (+24.88 %) |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | EVP, Chief Commerci ... | Sell | S | 0.00 | 54 | 0 | 30,143 | 30.2 K to 30.1 K (-0.18 %) |